Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF‑κB‑mediated alternative polarization of macrophages.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Oncology Report

• Publication date

  2017-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2017.5551PMID 28393222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TGF-β signalling in tumour associated macrophages.

  2017cited by this paper
• Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer

  2016cited by this paper
• Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.

  2016cited by this paper
• Hyperglycemia Differentially Affects Maternal and Fetal DNA Integrity and DNA Damage Response

  2016cited by this paper
• Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis.

  2016cited by this paper
• Critical role for the long non-coding RNA AFAP1-AS1 in the proliferation and metastasis of hepatocellular carcinoma

  2016cited by this paper
• Exosomes derived from gastric cancer cells activate NF-κB pathway in macrophages to promote cancer progression

  2016cited by this paper
• TGF-β Tumor Suppression through a Lethal EMT.

  2016cited by this paper
• Randomized, open‐label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma

  2016cited by this paper
• Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.

  2016cited by this paper
• Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages

  2015influential reference
• Current and future treatments for hepatocellular carcinoma.

  2015cited by this paper
• Receptor-Interacting Protein 140 Orchestrates the Dynamics of Macrophage M1/M2 Polarization

  2015cited by this paper
• Myeloid Cell TRAF3 Regulates Immune Responses and Inhibits Inflammation and Tumor Development in Mice

  2015cited by this paper
• 14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2.

  2015cited by this paper
• Tim-3 expression in tumour-associated macrophages: a new player in HCC progression

  2015influential reference
• M1-M2 balancing act in white adipose tissue browning – a new role for RIP140

  2015cited by this paper
• Periostin Secreted by Glioblastoma Stem Cells Recruits M2 Tumor-associated Macrophages and Promotes Malignant Growth

  2014cited by this paper
• Hepatocellular carcinoma: clinical frontiers and perspectives

  2014cited by this paper
• Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.

  2014cited by this paper
• Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation

  2014cited by this paper
• Receptor interacting protein 140 attenuates endoplasmic reticulum stress in neurons and protects against cell death

  2014cited by this paper
• RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis.

  2014cited by this paper
• Targeting NFKB by autophagy to polarize hepatoma-associated macrophage differentiation

  2013cited by this paper
• Distinct functions for RIP140 in development, inflammation, and metabolism.

  2013cited by this paper
• Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

  2013cited by this paper
• NF-κB-mediated degradation of the co-activator RIP140 regulates inflammatory response and contributes to endotoxin tolerance

  2012cited by this paper
• Identification and manipulation of tumor associated macrophages in human cancers

  2011cited by this paper
• Interleukin-6 in bone metastasis and cancer progression.

  2010cited by this paper
• Nuclear Factor-κB and Tumor-Associated Macrophages

  2010cited by this paper
• NF-kappaB as a critical link between inflammation and cancer.

  2009cited by this paper
• Cancer-related inflammation

  2008cited by this paper

• Rewiring tumor-associated macrophages in hepatocellular carcinoma

  2026cites this paper
• Advances in the Study of NRIP1 in Tumor Development

  2026cites this paper
• The prognostic marker NRIP1 is associated with tumor progression and immune infiltration in acute myeloid leukemia

  2025cites this paper
• NF-κB: Governing Macrophages in Cancer

  2024cites this paper
• Clinical usefulness of the lymphocyte-to-monocyte ratio and aggregate index of systemic inflammation in patients with esophageal cancer: a retrospective cohort study

  2023cites this paper
• Positive Association of Serum Vitamin B6 Levels with Intrapulmonary Lymph Node and/or Localized Pleural Metastases in Non-Small Cell Lung Cancer: A Retrospective Study

  2023cites this paper
• Revisiting of TAMs in tumor immune microenvironment: Insight from NF-κB signaling pathway.

  2023cites this paper
• Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma

  2023cites this paper
• Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis

  2023cites this paper
• The role of tumor‐associated macrophages in hepatocellular carcinoma progression: A narrative review

  2023cites this paper
• Activator-Mediated Pyruvate Kinase M2 Activation Contributes to Endotoxin Tolerance by Promoting Mitochondrial Biogenesis

  2021cites this paper
• The role of tumor-associated macrophages in primary hepatocellular carcinoma and its related targeting therapy

  2021cites this paper
• The PKM2 activator TEPP-46 attenuates MCD feeding-induced nonalcoholic steatohepatitis by inhibiting the activation of Kupffer cells.

  2021cites this paper
• Individualized precision treatment: Targeting TAM in HCC.

  2019cites this paper
• The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection

  2018cites this paper
• Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN‐induced hepatocellular carcinoma

  2018cites this paper
• NRIP1 (nuclear receptor interacting protein 1)

  2018cites this paper
• Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolization

  2018cites this paper
• The Emerging Role of Vitamin B6 in Inflammation and Carcinogenesis.

  2018cites this paper